Safety and Efficacy of C21 in Subjects With COVID-19

NCT04452435 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

206

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: C21
DRUG: Placebo

Sponsor

Vicore Pharma AB

Collaborators

[object Object]